APA (7th ed.) Citation

MMA, C., J, M., SAM, L., LGM, A., DSP, C., & D, P. (2023). Cost-effectiveness analysis of intravenous paricalcitol vs. oral calcitriol in the treatment of hyperparathyroidism secondary to chronic kidney disease. Jornal brasileiro de nefrologia, 45(1), 95. https://doi.org/10.1590/2175-8239-JBN-2022-0049en

Chicago Style (17th ed.) Citation

MMA, Cardoso, Machado-Rugolo J, Lima SAM, Andrade LGM, Curado DSP, and Ponce D. "Cost-effectiveness Analysis of Intravenous Paricalcitol Vs. Oral Calcitriol in the Treatment of Hyperparathyroidism Secondary to Chronic Kidney Disease." Jornal Brasileiro De Nefrologia 45, no. 1 (2023): 95. https://doi.org/10.1590/2175-8239-JBN-2022-0049en.

MLA (9th ed.) Citation

MMA, Cardoso, et al. "Cost-effectiveness Analysis of Intravenous Paricalcitol Vs. Oral Calcitriol in the Treatment of Hyperparathyroidism Secondary to Chronic Kidney Disease." Jornal Brasileiro De Nefrologia, vol. 45, no. 1, 2023, p. 95, https://doi.org/10.1590/2175-8239-JBN-2022-0049en.